Related Articles
Immunohistological study of cell cycle-related factors, oncogene expression, and cell proliferation in adenocarcinoma developed in Barrett's esophagus
BARRETTS CARCINOMA IN A 25-YEAR-OLD MAN WITH POINT MUTATION OF THE P53 TUMOR SUPPRESSOR GENE
p53 in esophageal adenocarcinoma: A critical reassessment of mutation frequency and identification of 72Arg as the dominant allele
Platelet 12-lipoxygenase and stem cells in Barrett's esophagus
Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus